Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Kuge, S.
Right arrow Articles by Mitomi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuge, S.
Right arrow Articles by Mitomi, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology 26:207-210 (1996)
© 1996 Foundation for Promotion of Cancer Research

Use of Metronidazole Gel to Control Malodor in Advanced and Recurrent Breast Cancer

Soichi Kuge1, Yutaka Tokuda1,, Masatoshi Ohta3, Akira Okumura1, Mitsuhiro Kubota1, Sayoshi Ninomiya2, Sadaaki Sawamura3, Hiroyasu Makuuchi1, Tomoo Tajima1 and Toshio Mitomi1

1 Department of Surgery, Tokai University School of Medicine Isehara, Kanagawa
2 Department of Pharmacy, Tokai University School of Medicine Isehara, Kanagawa
3 Department of Infectious Disease, Tokai University School of Medicine Isehara, Kanagawa

For reprints and all correspondence: Yutaka Tokuda, Department of Surgery, Tokai University School of Medicine, Bohseidai, Isehara, Kanagawa 259-11

Received December 19, 1995; accepted February 21, 1996

Intolerable malodor emanating from ulcerated tumors as a result of anaerobic infection is a serious problem in the management of advanced and recurrent breast cancer. Metronidazole can control this malodor, but its oral use may cause adverse reactions. We therefore formulated a metronidazole gel, since no equivalent preparation is commercially available in Japan, and used it in five female patients (four with advanced cancer and one with recurrent cancer) admitted to our hospital between March 1994 and July 1995. The patients were aged between 47 and 71 (median: 59) years, and the duration of morbidity in the four patients with advanced cancer ranged from 10 months to four years. In three patients, the tumors were larger than 10 cm x 10 cm. Metronidazole gel was applied to the surface of ulcerated tumors once or twice daily. Independent assessments by the patient, doctor and nurse were unanimous, and revealed that the malodor was alleviated in one patient after three days, and removed in four patients after two to five (median: four) days of metronidazole gel treatment. Culture of swabs showed a decrease or disappearance of anaerobic colonies. Adverse reactions characteristic of metronidazole did not occur. The topical use of metronidazole in a gel form will improve the quality of life for patients with malodorous ulcerated tumors and facilitate intensive treatment of the underlying disease.

Key Words: Breast cancer • Ulceration • Anaerobic infection • Malodor • Metronidazole gel


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
P. H. Warnke, E. Sherry, P. A.J. Russo, M. Sprengel, Y. Acil, J. P. Bredee, S. Schubert, J. Wiltfang, and I. N. Springer
Antibacterial Essential Oils Reduce Tumor Smell and Inflammation in Cancer Patients
J. Clin. Oncol., March 1, 2005; 23(7): 1588 - 1589.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.